, La prothèse amovible était une solution prothétique présente chez quatre participants, chacun avaient une prothèse amovible maxillaire et trois avaient aussi une prothèse amovible mandibulaire. Le seul patient édenté bi-maxillaire de notre étude ne possédait pas de prothèse amovible

, Deux prothèses complètes (n=2, 50%) -Une prothèse amovible partielle résine (n=1, 25%) -Une prothèse partielle métallique (n=1, 25%)

, La prothèse maxillaire était portée chez 75% des patients (n=3) alors que la moitié des prothèses avait des défauts d'intégrité (n=2, 50%), de rétention (n=2, 50%)

, Prothèses amovibles mandibulaires Trois patients présentaient une prothèse amovible mandibulaire : -Deux prothèses amovibles partielles métalliques (n=2, 66,7%) -Une prothèse amovible partielle résine (n=1, vol.3, p.33

, Aucune prothèse ne présentait de l'usure ou un manque d'intégrité, Les prothèses étaient portées dans les deux tiers des cas (n=2, 66,7%)

, Dix-huit patients avaient un édentement non compensé à la mandibule

, De la plaque était présente en excès dans la plupart des prothèses amovible maxillaires (75%) et mandibulaires (66,7%) (Tableau n°26)

, La moitié des détenteurs de prothèses amovibles ne les nettoyait jamais (n=2, 50%). L'autre moitié affirmait nettoyer leurs prothèses « plusieurs fois par semaine » (n=1, 25%)

. Conférence-internationale-de-la-santé, Constitution de l'organisation mondiale de la santé, vol.1, pp.1-18, 1946.

, Troubles mentaux et du comportement, Aide Mémoire Rapp Sur Santé Dans Monde, pp.1-4, 2001.

C. Stratégique-de-la-santé-mentale and . De-la-psychiatrie, Feuille de route : Santé mental et psychiatrie, pp.1-31, 2018.

, Améliorer la qualité du système de santé et maitriser les dépenses : propositions de l'assurance maladie pour 2020, pp.8-260, 2019.

. Who-|-schizophrenia, , 2019.

. Schizophrénie,

, Inserm -La science pour la santé, 2019.

D. Sur,

S. Drees and . France, L'état de santé de la population en France : Rapport, pp.260-91, 2017.

E. Petersen, The World Oral Health Report 2003 = Continuous improvement of oral health in the 21st century -the approach of the WHO Global Oral Health Programme, pp.1-34, 2003.

D. Frédéric, Prévention bucco-dentaire en psychiatrie, Santé Ment, pp.41-45, 2017.

N. Cockburn, A. Pradhan, M. Taing, S. Kisely, and P. Ford, Oral health impacts of medications used to treat mental illness, J Affect Disord, vol.233, pp.184-93, 2017.

, American Psychiatric Association. Manuel diagnostique et statistique des troubles mentaux. 5 e éd, 2015.

S. Hautecouverture, F. Limousin, and F. Rouillon, Épidémiologie des troubles schizophréniques, Presse Médicale, vol.35, issue.3, pp.461-469, 2006.

C. Gourier-frery, C. Chee, C. Beltzer, and N. , Prévalence de la schizophrénie et autres troubles psychotiques en France métropolitaine, National Health Service. Schizophrenia, vol.29, issue.8, 2014.

M. Disponible-sur-;-ek, S. Wicks, A. Svensson, S. Idring, and C. Dalman, Advancing Paternal Age and Schizophrenia: The Impact of Delayed Fatherhood, Schizophr Bull, vol.41, issue.3, pp.708-722, 2015.

A. Brown, C. Schaefer, R. Wyatt, M. Begg, R. Goetz et al., Paternal Age and Risk of Schizophrenia in Adult Offspring, Am J Psychiatry, vol.159, issue.9, pp.1528-1561, 2002.

Y. Lee, S. Cherkerzian, L. Seidman, G. Papandonatos, D. Savitz et al., Maternal Bacterial Infection During Pregnancy and Offspring Risk of Psychotic Disorders: Variation by Severity of Infection and Offspring Sex, Am J Psychiatry, pp.1-10, 2019.

E. Vassos, C. Pedersen, R. Murray, D. Collier, and C. Lewis, Meta-analysis of the association of urbanicity with schizophrenia, Schizophr Bull, vol.38, issue.6, pp.1118-1141, 2012.

C. Wang and Y. Zhang, Schizophrenia in mid-adulthood after prenatal exposure to the Chinese : Famine of 1959-1961, Schizophr Res, vol.184, pp.21-26, 2017.

C. Cheng, E. Loh, C. Lin, C. Chan, and T. Lan, Birth seasonality in schizophrenia: effects of gender and income status, Psychiatry Clin Neurosci, vol.67, issue.6, pp.426-459, 2013.

J. Kim, C. Park, J. Choi, E. Park, H. Tchoe et al., The association between season of birth, age at onset, and clozapine use in schizophrenia, Acta Psychiatr Scand, vol.136, issue.5, pp.445-54, 2017.

C. Wang and Y. Zhang, Season of birth and schizophrenia: Evidence from China, Psychiatry Res, vol.253, issue.1, pp.189-96, 2017.

R. Mcintyre, L. Leiter, Y. Lau, D. Stip, E. Ur et al., Glycemia and Antipsychotic Medications: An Expert Consensus Review, Can J Diabetes, vol.29, issue.2, pp.113-134, 2005.

L. Lu, M. Dong, L. Zhang, X. Zhu, G. Ungvari et al., Prevalence of suicide attempts in individuals with schizophrenia: a meta-analysis of observational studies, Epidemiol Psychiatr Sci, pp.1-10, 2019.

K. Kowalec, Y. Lu, A. Sariaslan, J. Song, A. Ploner et al., Increased schizophrenia family history burden and reduced premorbid IQ in treatment-resistant schizophrenia: a Swedish National Register and Genomic Study, Mol Psychiatry, pp.1-9, 2019.

D. Lichtermann, J. Ekelund, E. Pukkala, A. Tanskanen, and J. Lonnqvist, Incidence of cancer among persons with schizophrenia and their relatives, Arch Gen Psychiatry, vol.58, issue.6, pp.573-581, 2001.

, Les médicaments de la schizophrénie -EurekaSanté par VIDAL

. Eurekasanté, , 2019.

S. Disponible-sur-;-stubner, E. Rustenbeck, R. Grohmann, G. Wagner, R. Engel et al., Severe and Uncommon Involuntary Movement Disorder due to Psychotropic Drugs

, PharmacoPsychiatry, vol.37, issue.1, pp.54-64, 2004.

J. Munro, D. O'sullivan, C. Andrews, A. Arana, A. Mortimer et al., Active monitoring of 12760 clozapine recipients in the UK and Ireland, Br J Psychiatry, vol.175, issue.6, pp.576-80, 1999.

A. Murru, I. Pacchiarotti, A. Nivoli, . Grande-iria, F. Colom et al., What we know and what we don't know about the treatment of schizoaffective disorder, Eur Neuropsychopharmacol, vol.21, issue.9, pp.680-90, 2011.

J. Perala, J. Suvisaari, S. Saarni, . Kuoppasalimi, E. Isometsa et al., Lifetime Prevalence of Psychotic and Bipolar Disorders in a General Population, Arch Gen Psychiatry, vol.64, issue.1, pp.19-28, 2007.

T. Laursen, R. Labouriau, R. Licht, A. Bertelsen, T. Munk-olsen et al., Family History of Psychiatric Illness as a Risk Factor for Schizoaffective Disorders : A Danish Register-Based Cohort Study, Arch Gen Psychiatry, vol.62, issue.8, pp.841-849, 2005.

H. Jacquet, C. Demily, E. Houy, B. Hecketsweiler, J. Bou et al.,

, Hyperprolinemia is a risk factor for schizoaffective disorder, Mol Psychiatry, vol.10, issue.5, pp.479-85, 2005.

E. Manrique-garcia, S. Zammit, C. Dalman, T. Hemmingsson, and P. Allebek, Cannabis use and depression: a longitudinal study of a national cohort of Swedish conscripts, BMC Psychiatry, vol.12, issue.112, pp.1-7, 2012.

C. Vardaxi, X. Gonda, and K. Fountoukalis, Life events in schizoaffective disorder: a systematic review, J Affect Disord, vol.227, pp.563-70, 2018.

W. Fenton, T. Mcglashan, B. Victor, and C. Blyler, Symptoms, subtype, and suicidality in patients with schizophrenia spectrum disorders, Am J Psychiatry, vol.154, issue.2, pp.199-204, 1997.

E. Cascade, A. Kalali, and P. Buckley, Treatment of Schizoaffective Disorder, Psychiatry Edgemont, vol.6, issue.3, pp.15-22, 2009.

C. Hospitalier-de and C. Perrens, Rapport d'activité, 2018.

F. Denis, G. Milleret, T. Wallenhorst, M. Carpentier, N. Rude et al., Oral health in schizophrenia patients: A French Multicenter Cross-Sectional Study, Presse Médicale, vol.48, issue.2, pp.89-99, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02152879

A. Annamalai, U. Kosir, and C. Tek, Prevalence of obesity and diabetes in patients with schizophrenia, World J Diabetes, vol.8, issue.8, pp.390-396, 2017.

D. Hert, M. Winkel, R. Eyck, D. Hanssens, L. Wampers et al., Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study, Clin Pract Epidemiol Ment Health, vol.27, issue.2, p.14, 2006.

M. Connoly and C. Kelly, Lifestyle and physical health in schizophrenia, Adv Psychiatr Treat, vol.11, issue.2, pp.125-157, 2005.

M. Bak, A. Fransen, J. Janssen, J. Van-os, and M. Drukker, Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis, Plos One, vol.9, issue.4, pp.1-19, 2014.

C. Correll, M. Solmi, N. Veronese, B. Bortolato, S. Rosson et al.,

, Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls, World Psychiatry, vol.16, issue.2, pp.163-80, 2017.

D. Hert, M. Schreurs, V. Vancampfort, D. Winkel, and R. , Metabolic syndrome in people with schizophrenia: a review, World Psychiatry, vol.8, issue.1, pp.15-22, 2009.

M. Chiu, F. Rahman, S. Vigod, A. Wilton, and P. Kurdyak, Temporal trends in cardiovascular disease risk factor profiles in a population-based scizophrenia sample: a repeat cross-sectional study, J Epidemiol Community Health, vol.72, issue.1, pp.71-78, 2018.

M. Darling and T. Arendorf, Effects of cannabis smoking on oral soft tissues, Community Dent Oral Epidemiol, vol.21, issue.2, pp.78-81, 1993.

M. Schulz-katterbach, T. Imfeld, and C. Imfeld, Cannabis and caries -Does regular cannabis use increase the risk of caries in cigarette smokers, Schweiz Monatsschr Zahnmed, vol.119, issue.6, pp.576-83, 2009.

M. Thomson, W. Poulton, R. Broadbent, J. Moffitt, T. Caspi et al., Cannabis smoking and periodontal disease among young adults, J Am Med Assoc, vol.299, issue.5, pp.525-556, 2008.

A. Friedlander and S. Marder, The psychopathology medical management and dental implications of schizophrenia, J Am Dent Assoc, vol.133, issue.5, pp.603-613, 2002.

R. Curien, H. Moizan, S. Rouchiche, S. Bergmann, and E. Gerard, Evaluation de l'influence des psychotropes sur la santé bucco-dentaire chez une population de patients hospitalisés en secteur psychiatrique, Inf Dent, vol.88, issue.9, pp.439-480, 2006.

D. Winn, Tobacco use and oral disease, J Dent Educ, vol.65, issue.4, pp.306-316, 2001.

J. Koskinen, J. Lohonen, H. Koponen, M. Isohanni, and J. Miettunen, Prevalence of alcohol use disorders in schizophrenia -a systematic review and meta-analysis, Acta Psychiatr Scand, vol.120, issue.2, pp.85-96, 2009.

G. Ogden, Alcohol and mouth cancer, Br Dent J, vol.225, issue.9, pp.880-883, 2008.

V. Bagnardi, M. Rota, E. Botteri, I. Tramacere, F. Islami et al., Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis, Br J Cancer, vol.112, issue.3, pp.580-93, 2015.

S. Jovanovic, S. Milovanovic, I. Gajic, J. Mandic, M. Latas et al., Oral Health status of psychiatric in patients in serbia and implications for their dental care, Croat Med J, vol.51, issue.5, pp.443-50, 2010.

E. Velasco-ortega, L. Monsalve, I. Ortiz-garcia, A. Jimenez-guerra, J. Lopez-lopez et al., Dental caries status of patients with schizophrenia in seville, Spain : a casecontrol study, BMC Res Notes, vol.10, issue.50, p.50, 2017.

D. Agarwal, A. Kumar, B. C. Manjunath, R. Shyam, V. Kumar et al., Effectiveness of oral health education on oral hygiene status among schizophrenic patients : A randomized controlled study. Spec Care Dent, vol.39, pp.1-7, 2019.

D. Villadsen and M. Sorensen, Oral Hygiene -A Challenge in Everyday Life for people with schizophrénia, Issues Ment Health Nurs, vol.38, issue.8, pp.1-7, 2017.

A. Kossioni, G. Kossionis, and A. Polychronopoulou, Oral health status of elderly hospitalised psychiatric patients, Gerodontology, vol.29, issue.4, pp.272-83, 2012.

E. Winocur, H. Hermesh, D. Littner, R. Shiloh, L. Peleg et al., Signs of bruxism and temporomandibular disorders among psychiatric patients. Oral Surg Oral Med Oral Pathol Oral Radiol, vol.103, pp.60-63, 2007.

A. Araujo, D. Nascimento, M. , D. Sena, E. Baptista et al., Temporomandubular disorders in patients with schizophrenia using antipsychotic agents. Drug Health Care Patients Saf, vol.10, pp.21-28, 2014.

R. Balasubramaniam and S. Ram, Orofacial movement disorders, Oral Maxillofac Surg Clin N Am, vol.20, issue.2, pp.273-85, 2008.

E. Velasco-ortega, L. Monsalve, R. Medel-soteras, J. J. Segura-egea, and C. Velasco-ponferrada, Temporomandibular disorders among schizophrenic patients : a case-control study, Med Oral Patol Oral Cir Bucal, vol.10, issue.4, pp.315-337, 2005.

O. Gurbuz, G. Alatas, and K. E. , Prevalence of temporomandibular disorder signs in patients with schizophrenia, J Oral Rehabil, vol.36, issue.12, pp.864-71, 2009.

T. Arjun, H. Sudhir, R. Sahu, V. Saxena, E. Saxena et al., Assessment of oral mucosal lesions among psychiatric inmates residing in central jail, Indian J Psychiatry, vol.56, issue.3, pp.265-70, 2014.

S. Zusman, A. Ponizovsky, D. Dekel, A. Masarwa, T. Ramon et al., An assessment of the dental health of chronic institutionalized patients withpsychiatric disease in Israel. Spec Care Dent, vol.30, pp.18-22, 2010.

J. Lindhe, R. Ranney, I. Lamster, A. Charles, C. Chung et al., Consensus report : chronic periodontititis, Ann Periodontol, vol.4, issue.1, p.38, 1999.

A. Eltas, S. Kartalci, S. Eltas, S. Dundar, and M. Uslu, An assessment of periodontal health in patients with schizophrenia and taking antipsychotic medication, Int J Dent Hyg, vol.11, issue.2, pp.78-83, 2013.

C. M. Wey, S. Y. Loh, J. G. Doss, . Bakar-abdul, and S. Kisely, The oral health of people with chronic schizophrenia: A neglected public health burden, Aust New Zeland J Psychiatry, vol.50, issue.7, pp.685-94, 2015.

S. Fosse-edorh, L. Mandereau-bruno, and C. Piffaretti,

F. Santé-publique, , 2018.

D. Sur,

H. Loe, Periodontal Disease : The sixth complication of diabetes mellitus, Diabetes Care, vol.16, issue.1, pp.329-363, 1993.

M. Shlossman, W. Knowler, D. Pettitt, and R. Genco, Type 2 diabetes mellitus and periodontal disease, J Am Dent Assoc, vol.121, issue.4, pp.532-538, 1990.

A. Singh, B. Purohit, and P. Mitall, Periodontal predicaments and associated risk factors among patients with schizophrenia, Neurol Psychiatry Brain Res, vol.32, pp.36-41, 2019.

P. Marsh, Dental plaque as a biofilm and a microbial community -implications for health and disease, BMC Oral Health, vol.6, issue.1, p.14, 2006.

L. Tenuta, C. Fernandez, A. Brandao, and J. Cury, Titratable acidity of beverages influences salivary pH recovery, Braz Oral Res, vol.29, issue.32, p.1, 2015.

A. Jakobsen, H. Speyer, H. Norgaard, M. Karlsen, C. Hjorthoj et al., Dietary patterns and physical activity in people with schizophrenia and increased waist circumference, Schizophr Res, vol.199, pp.109-124, 2018.

R. Amani, Is dietary pattern of schizophrenia patients different from healthy subjects ? BMC Psychiatry, vol.7, pp.1-5, 2007.

M. Kumar, G. Chandu, and M. Shafiulla, Oral health status and treatment needs in institutionalized psychiatric patients : one year descriptive cross sectional study, Indian J Dent Res, vol.17, issue.4, pp.171-178, 2006.

V. Djordjevic, M. Jovanovic, B. Milicic, V. Stefanovic, and S. Dejanovic, Prévalence of dental caries in hospitalized patients with schizophrenia, Vojnosanit Pregl, vol.73, issue.12, pp.1102-1110, 2016.

M. Yang, P. Chen, M. He, M. Lu, H. Wang et al., Poor oral health in patients with schizophrenia: A systematic review and meta-analysis, Schizophr Res, vol.201, pp.3-9, 2018.

S. Kisely, L. Quek, J. Pais, R. Lallo, N. Johnson et al., Advanced dental disease in people withsevere mental illness: systematic reviewand meta-analysis, Br J Psychiatry, vol.199, issue.3, pp.187-93, 2011.

V. Bertaud-gounot, V. Kovess-masfety, C. Perrus, G. Trohel, and F. Richard, Oral health status and treatment needs among psychiatric inpatients in Rennes, France: a Cross-sectional study, BMC Psychiatry, vol.13, issue.227, pp.1-9, 2013.

S. Kay, A. Fiszbein, and L. Opler, The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia, Schizophr Bull, vol.13, issue.2, pp.261-76, 1987.

A. Arnaiz, M. Zummaraga, I. Diez-atuna, J. Uriarte, and J. Moro, Perez-Ansorena M. Oral health and the symptoms of schizophrenia, Psychiatry Res, vol.188, issue.1, pp.24-32, 2011.

D. Mos, Saliva secretion disorder in a schizophrenic patient a problem in dental and psychiatric treatment a case report, Ann Gen Psychiatry, vol.14, issue.14, pp.1-5, 2015.

Y. Hashimoto, J. Uno, T. Miwa, M. Kurihara, H. Tanifuji et al., Effects of antipsychotic polypharmacy on side effects and concurrent use of medications in schizophrenic outpatients, Psychiatry Clin Neurosci, vol.66, issue.5, pp.405-415, 2012.

D. Ngo, M. Thomson, W. Subramaniam, M. Abdin, E. Ang et al., The oral health of long-term psychiatric inpatients in Singapore, Psychiatry Res, vol.266, pp.206-217, 2018.

C. Scully, Drug effects on salivary glands : dry mouth, Oral Dis, vol.9, issue.4, pp.165-76, 2003.

A. Okamoto, H. Miyachi, K. Tanka, D. Chikazu, and H. Miyaoka, Relationship between xerostomia and psychotropic drugs in patients with schizophrenia : evaluation using an oral moisture meter, J Clin Pharm Ther, vol.41, issue.6, pp.684-692, 2016.

M. Tohen, R. Chengappa, T. Suppes, C. Zarate, J. Calabrese et al., Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy, Arch Gen Psychiatry, vol.59, issue.1, pp.62-71, 2002.

A. Singh, P. Mittal, P. Goel, B. Purohit, and R. Thukral, Severity of illness and extra pyramidal symptoms as predictors for oral diseases among patients with schizophrenia, Acta Odontol Scand, vol.75, issue.3, pp.220-226, 2017.

E. Lai, C. Hsieh, M. Wong, S. Lin, Y. Yang et al., Comparative risk of oral ulcerations among antipsychotics users -population-based retrospective cohort study, Pharmacoepidemiol Drug Saf, vol.25, issue.2, pp.123-155, 2016.

A. Grinshpoon, S. Zusman, A. Weizman, and A. Ponizovsky, Dental Health and the Type of Antipsychotic Treatment in Inpatients with Schizophrenia, Isr J Psychiatry Relat Sci, vol.52, issue.2, pp.114-88, 2015.

S. Dinwiddie, H. Dezheng, and O. Gottlieb, The Course of Myalgia and Headache After Electroconvulsive Therapy, J ECT, vol.26, issue.2, pp.116-136, 2010.

C. Andrade, S. Arumugham, and J. Thirthalli, Adverse Effects of Electroconvulsive Therapy, Psychiatr Clin North Am, vol.39, issue.3, pp.513-543, 2016.

B. Muzyka, M. Glass, and O. Glass, Oral Health in Electroconvulsive Therapy :A Neglected Topic, J ECT, vol.33, issue.1, pp.12-17, 2017.

K. Chu, Y. Chou, P. Chi, L. Chiu, and H. , Dental prosthetic treatment needs of inpatientswith schizophrenia in Taiwan: a cross-sectional study, BMC Oral Health, 2013.

R. Lallo, S. Kisely, H. Amarasinghe, R. Perera, and N. Johnson, Oral health of patients on psychotropic medications: a study of outpatients in Queensland, Australas Psychiatry, vol.21, issue.4, pp.338-380, 2013.

P. Teng, J. Su, C. Lai, and T. , Oral health of psychiatric inpatients: a survey of central Taiwan hospitals, Gen Hosp Psychiatry, vol.33, issue.3, pp.253-262, 2011.

M. Aljabri, I. Gadibalban, A. Kalbousch, H. Sadek, and H. Abed, Barriers to special care patients with mental illness receiving oral healthcare : A cross sectional study in the Holy City of Makkah, Saudi Arabia, Saudi Med J, vol.39, issue.4, pp.419-442, 2018.

H. Autorité-de-santé, Actes et préstations longue durée: Schizophrénies. Serv Affect Longue Durée Accords Conv, pp.1-13, 2017.

, Service médicale de l'assurance maladie. Exonération du ticket modérateur en rapport avec une Affection de Longue Durée et odontologie

, Direction Régionale du Service médical PACA Corse, 2015.

R. Mccreadie, H. Stevens, J. Henderson, D. Hall, R. Mccaul et al., The dental health of people with schizophrenia, Acta Psychiatr Scand, vol.110, issue.4, pp.306-316, 2004.

H. Klein, C. Palmer, and J. Knutson, Studies on Dental Caries. I. Dental Status and Dental Needs of Elementary School Children, Public Health Rep, vol.53, pp.751-65, 1938.

H. Klein and C. Palmer, Studies on dental caries : Sex differences in dental caries experience of elementary school children, Public Health Rep, vol.53, issue.38, pp.1685-90, 1938.

H. Klein and C. Palmer, Dental Caries in American Indian Children, Public Health Bull, issue.239, pp.1-54, 1937.

J. Greene and J. Vermillon, The simplified oral hygiene index, J Am Dent Assoc, vol.68, issue.1, pp.7-13, 1964.

, Simplified Oral Hygiene Index | OHI-S -Malmö University

D. Sur, Oral-Hygiene-Indices/Simplified-Oral-Hygiene-Index

M. Thomson, W. , C. J. Spencer, J. Williams, and S. , The Xerostomia inventory: a multi-item approach to measuring dry mouth, Community Dent Health, vol.16, pp.12-19, 1999.

M. Thomson, W. Van-der-putten, G. , D. Baat, C. Ikebe et al., Shortening the Xerostomia Inventory. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, vol.112, pp.322-329, 2011.

A. Lovgren, C. Visscher, B. Haggman-henrikson, F. Lobbezoo, S. Marklund et al., Validity of three screening questions (3Q/TMD) in relation to the DC/TMD, J Oral Rehabil, vol.43, issue.10, pp.729-765, 2016.

A. Buzyn and G. Darmanin, Arrêté du 20 août 2018 portant approbation de la convention nationale organisant les rapports entre les chirurgiens-dentistes libéraux et l'assurance maladie

. Sect, Texte 5 sur 147, SSAS1821640A Aout, 2018.

B. Cazeneuve, M. Touraine, and S. Neuville, Décret n° 2017-708 du 2 mai 2017 modifiant le référentiel d'accès à la prestation de compensation fixé à l'annexe 2-5 du code de l'action sociale et des familles, 2017.

J. Ratliff, L. Palmese, E. Reutenauer, E. Liskov, C. Grilo et al., The effect of dietary and physical activity pattern on metabolic profile in individuals with schizophrenia: A crosssectional study, Compr Psychiatry, vol.53, issue.7, pp.1028-1061, 2012.

M. Salahudeen, S. Duffull, and P. Nishtala, Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review, BMC Geriatr, vol.15, issue.31, pp.1-14, 2015.

C. Duran and M. Azermai, Vandel Stichele R. Systematic review of anticholinergic risk scales in older adults, Eur J Clin Pharmacol, vol.69, issue.7, pp.1485-96, 2013.

F. Denis, M. Hamad, B. Trojak, S. Tubert-jeannin, C. Rat et al., Psychometric characteristics of the "General Oral Health Assessment Index (GOHAI) » in a French representative sample of patients with schizophrenia, BMC Oral Health, vol.17, issue.1, p.75, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01670772

S. Tubert-jeannin, P. Riordan, A. Morel-papernot, S. Porcheray, and S. Saby-collet, Validation of an oral health quality of life index (GOHAI) in France, Community Dent Oral Epidemiol, vol.31, pp.275-84, 2003.

K. Atchison and T. Dolan, Development of the Geriatric Oral Health Assessment Index, J Dent Educ, vol.54, issue.11, pp.680-687, 1990.

Y. Dailey, G. Humphris, and M. Lennon, The use of dental anxiety questionnaires: a survey of a group of UK dental practitioners, Br Dent J, vol.190, issue.8, pp.450-453, 2001.

G. Humphris, H. Clarke, and R. Freeman, Does completing a dental anxiety questionnaire increase anxiety? A randomised controlled trial with adults in general dental practice, Br Dent J, vol.201, issue.1, pp.33-38, 2006.

A. Thomas, E. Lavrentzou, C. Karouzous, and C. Kontis, Factors which influence the oral condition of chronic schizophrenia patients. Spec Care Dent, vol.16, pp.84-90, 1996.

E. Velasco-ortega, J. J. Segura-egea, S. Cordoba-arenas, A. Jimenez-guerra, L. Monsalve-guil et al., A comparison of the dental status and treatment needs of older adults with and without chronic m ental illness in Sevilla, Spain. Med Oral Patol Oral Cirugia Bucal, vol.18, pp.71-76, 2013.

S. Lewis, R. Jagger, and E. Treasure, The oral health of psychiatric in-patients in South Wales. Spec Care Dent, vol.21, pp.182-188, 2001.

I. Angelillo, C. Nobile, M. Pavia, D. Fazio, P. Puca et al., Dental health and treatment needs in institutionalized psychiatric patients in Italy, Community Dent Oral Epidemiol, vol.23, issue.6, pp.360-364, 1995.

D. Corridore, F. Guerra, L. Marra, C. Ottolenghi, and L. , Oral Health Status and Oral Health-Related Quality of Life in Italian Deinstitutionalized Psychiatric Patients, Clin Ther, vol.168, issue.2, pp.77-83, 2017.

K. Chu, Y. Chou, P. Chiu, H. , and C. , Comparison of oral health between inpatients with schizophrenia and disabled people or the general population, J Formos Med Assoc, vol.111, issue.4, pp.214-223, 2012.

F. Ocde, Agriculture Organization of the United Nations. Sugar. OECD-FAO Agric, pp.139-276, 2018.

S. Organisation-mondiale-de-la, Guidelines : Sugar intake for adults and children, pp.1-59, 2015.

H. Tani, H. Uchida, T. Suzuki, and Y. Shibuya, Dental conditions in inpatients with schizophrenia: A large-scale multi-site survey, BMC Oral Health, vol.12, issue.32, pp.1-6, 2012.

K. Chu, Y. Chou, P. Chi, L. Chiu, and H. , The relationship between body ass index, the use of second-generation antipsychotics, and dental caries among hospitalized patients with schizophrenia, Int J Psychiatry Med, vol.41, issue.4, pp.343-53, 2011.

B. Stubbs, T. Thompson, S. Acaster, D. Vancampfort, F. Gaughran et al., Decreased pain sensitivity among people with schizophrenia: a meta-analysis of experimental pain induction studies, Pain, vol.156, issue.11, pp.2121-2152, 2015.

H. Autorité-de-santé, Commission de la transparence : avis : clozapine, pp.1-25, 2017.

H. Autorité-de-santé, Avis de la commision nationale de l'évaluation des dispositifs médicaux et des technologies de sante : AEQUASYAL. commision nationale de l'évaluation des dispositifs médicaux et des technologies de sante, pp.1-14, 2016.

J. Nielsen, P. Munk-jorgensen, S. Skadhese, and C. Correll, Determinants of poor dental care in patients with schizophrenia: A Historical, Prospective Database Study, J Clin Psychiatry, vol.72, issue.2, pp.140-143, 2011.

A. Buzyn, Dispositions relatives à la protection complémentaire en matière de santé, 2018.

G. Humphris, T. Dyer, and P. Robinson, The modified dental anxiety scale: UK general public population norms in 2008 with further psychometrics and effects of age, BMC Oral Health, vol.9, issue.20, pp.1-8, 2009.

N. Revel, M. Ronat, T. Soulie, and P. Denoyelle, Avis relatif à l'avenant n° 3 à la convention nationale organisant les rapports entre les chirurgiens-dentistes et l'assurance maladie signée le 21 juin, JORF n°0032, SSAS2003111V févr 7, 2018.

C. Rat, A. Peteuil, M. Reynaud, I. Millot, M. Carpentier et al., Un partenariat patients schizophrènes-soignants pour conduire un programme d'éducation en santé orale, Santé Publique, vol.31, issue.4, pp.405-420, 2019.

F. Denis, I. Millot, N. Abello, M. Carpentier, A. Peteuil et al., Study protocol: a cluster randomized controlled trial to assess the effectiveness of a therapeutic educational program in oral health for persons with schizophrenia, Int J Ment Health Syst, vol.10, issue.65, pp.1-10, 2016.

, Agence nationale de sécurité du médicament et des produits de santé

, Agence nationale de sécurité du médicament et des produits de santé, Agence nationale de sécurité du médicament et des produits de santé. Résumé des caractéristiques du produit : Entonox [Internet, 2017.

, Annexe n°1 : Questionnaire, p.2019

, Annexe n°2 : Réponses de la première question du GOHAI des patients atteints de schizophrénie (SCZ) et de troubles schizoaffectifs (TSA)

, Annexe n°3 : Réponses de la septième question du GOHAI des patients atteints de schizophrénie (SCZ) et de troubles schizoaffectifs (TSA)

, Annexe n°4 : Réponses de la neuvième question du GOHAI des patients atteints de schizophrénie (SCZ) et de troubles schizoaffectifs (TSA)

, Annexe n°5 : Réponses de la douzième question du GOHAI des patients atteints de schizophrénie (SCZ) et de troubles schizoaffectifs (TSA)

, Annexe n°6 : Activité anticholinergique des médicaments

L. Vu, . Président, and . Jury, Signature : Vu, la Directrice de l'UFR des Sciences Odontologiques